Glucagon-Like Peptide 1 Receptor Agonists are Associated With Reduced Risk of Hepatic Encephalopathy in Cirrhosis

By afschroeder • May 26, 2026

Singh V, Wang M, Ebinger J, Velazquez A, Cheng S, Kwan AC, Trivedi HD. Glucagon-Like Peptide 1 Receptor Agonists are Associated With Reduced Risk of Hepatic Encephalopathy in Cirrhosis. J Clin Gastroenterol. 2026 May 25. doi: 10.1097/MCG.0000000000002396. Epub ahead of print. PMID: 42183591.

Tags: Cardiology/Epi, Cedars Sinai DoM, Cirrhosis, glp-1 ra, Hepatic encephalopathy, liver cancer, Publications

Outcome of Patients Presenting With High-Risk Pulmonary Embolism Treated With Mechanical Thrombectomy: A Subgroup Analysis From the STRIKE-PE Study

Sharp ASP, Dohad SY, Weinberg I, Kurzyna M, Davis HC, Stepniewski J, Perkowski PE, Holden A, West FM, Keeling WB, Parikh SA, Moriarty JM. Outcome[...]

Temporal Trends and Future Projections of Pulmonary Embolism and Top Contributing Causes of death in the United States, 1968-2040: insights from the CDC WONDER database

Khan S, Abbas F, Hassan M, Hussain M, Ahmed M, Ahsan A, Qureshi S, Khalid N, Sajjad A, Baig M, Waqas SA, Fonarow GC, Greene[...]

Temporal Trends and Forecasted Cardiac Arrest and Hypertension-Related Mortality in U.S. Adults, 2000-2035: A Nationwide CDC WONDER Multiple Cause-of-Death Study

Khan S, Arsheen F, Fareed M, Mari T, Hussain M, Memon P, Hussain SMA, Hassan M, Naz A, Ejaz Y, Fonarow GC, Aminpoor H. Temporal[...]